Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions

被引:42
作者
Ferrara, Michele [1 ]
Chialli, Ginevra [1 ,2 ]
Ferreira, Lorena Maria [3 ]
Ruggieri, Elena [1 ,2 ]
Careccia, Giorgia [1 ,2 ]
Preti, Alessandro [4 ]
Piccirillo, Rosanna [5 ]
Bianchi, Marco Emilio [1 ,2 ]
Sitia, Giovanni [3 ]
Venereau, Emilie [2 ]
机构
[1] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Chromatin Dynam Unit, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Expt Hepatol Unit, Milan, Italy
[4] HMGBiotech Srl, Milan, Italy
[5] Mario Negri Inst Pharmacol Res IRCCS, Dept Neurosci, Milan, Italy
关键词
inflammation; regeneration; injury; leukocyte; tumor; cancer cachexia; muscle; liver; GROUP BOX 1; PROTEIN HMGB1; INFLAMMATORY CELLS; SKELETAL-MUSCLE; RECRUITMENT;
D O I
10.3389/fimmu.2020.01122
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute inflammation is a complex biological response of tissues to harmful stimuli, such as pathogens or cell damage, and is essential for immune defense and proper healing. However, unresolved inflammation can lead to chronic disorders, including cancer and fibrosis. The High Mobility Group Box 1 (HMGB1) protein is a Damage-Associated Molecular Pattern (DAMP) molecule that orchestrates key events in inflammation by switching among mutually exclusive redox states. Fully reduced HMGB1 (frHMGB1) supports immune cell recruitment and tissue regeneration, while the isoform containing a disulphide bond (dsHMGB1) promotes secretion of inflammatory mediators by immune cells. Although it has been suggested that the tissue itself determines the redox state of the extracellular space and of released HMGB1, the dynamics of HMGB1 oxidation in health and disease are unknown. In the present work, we analyzed the expression of HMGB1 redox isoforms in different inflammatory conditions in skeletal muscle, from acute injury to muscle wasting, in tumor microenvironment, in spleen, and in liver after drug intoxication. Our results reveal that the redox modulation of HMGB1 is tissue-specific, with high expression of dsHMGB1 in normal spleen and liver and very low in muscle, where it appears after acute damage. Similarly, dsHMGB1 is highly expressed in the tumor microenvironment while it is absent in cachectic muscles from the same tumor-bearing mice. These findings emphasize the accurate and dynamic regulation of HMGB1 redox state, with the presence of dsHMGB1 tightly associated with leukocyte infiltration. Accordingly, we identified circulating, infiltrating, and resident leukocytes as reservoirs and transporters of dsHMGB1 in tissue and tumor microenvironment, demonstrating that the redox state of HMGB1 is controlled at both tissue and cell levels. Overall, our data point out that HMGB1 oxidation is a timely and spatially regulated process in physiological and pathological conditions. This precise modulation might play key roles to finetune inflammatory and regenerative processes.
引用
收藏
页数:13
相关论文
共 35 条
[21]   Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia [J].
Martinelli, G. B. ;
Olivari, D. ;
Cecconi, A. D. Re ;
Talamini, L. ;
Ottoboni, L. ;
Lecker, S. H. ;
Stretch, C. ;
Baracos, V. E. ;
Bathe, O. F. ;
Resovi, A. ;
Giavazzi, R. ;
Cervo, L. ;
Piccirillo, R. .
ONCOGENE, 2016, 35 (48) :6212-6222
[22]   Alarmins: chemotactic activators of immune responses [J].
Oppenheim, JJ ;
Yang, D .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (04) :359-365
[23]   Release of chromatin protein HMGB1 by necrotic cells triggers inflammation [J].
Scaffidi, P ;
Misteli, T ;
Bianchi, ME .
NATURE, 2002, 418 (6894) :191-195
[24]   HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 [J].
Schiraldi, Milena ;
Raucci, Angela ;
Martinez Munoz, Laura ;
Livoti, Elsa ;
Celona, Barbara ;
Venereau, Emilie ;
Apuzzo, Tiziana ;
De Marchis, Francesco ;
Pedotti, Mattia ;
Bachi, Angela ;
Thelen, Marcus ;
Varani, Luca ;
Mellado, Mario ;
Proudfoot, Amanda ;
Bianchi, Marco Emilio ;
Uguccioni, Mariagrazia .
JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (03) :551-563
[25]   Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice [J].
Sitia, Giovanni ;
Iannacone, Matteo ;
Mueller, Susanne ;
Bianchi, Marco E. ;
Guidotti, Luca G. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (01) :100-107
[26]   High mobility group box 1 orchestrates tissue regeneration via CXCR4 [J].
Tirone, Mario ;
Ngoc Lan Tran ;
Ceriotti, Chiara ;
Gorzanelli, Andrea ;
Canepari, Monica ;
Bottinelli, Roberto ;
Raucci, Angela ;
Di Maggio, Stefania ;
Santiago, Cesar ;
Mellado, Mario ;
Saclier, Marielle ;
Francois, Stephanie ;
Careccia, Giorgia ;
He, Mingzhu ;
De Marchis, Francesco ;
Conti, Valentina ;
Ben Larbi, Sabrina ;
Cuvellier, Sylvain ;
Casalgrandi, Maura ;
Preti, Alessandro ;
Chazaud, Benedicte ;
Al-Abed, Yousef ;
Messina, Graziella ;
Sitia, Giovanni ;
Brunelli, Silvia ;
Bianchi, Marco Emilio ;
Venereau, Emilie .
JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 215 (01) :303-318
[27]   Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis [J].
Urbonaviciute, Vilma ;
Meister, Silke ;
Fuernrohr, Barbara G. ;
Frey, Benjamin ;
Gueckel, Eva ;
Schett, Georg ;
Herrmann, Martin ;
Voll, Reinhard E. .
AUTOIMMUNITY, 2009, 42 (04) :305-307
[28]   HMGB1 as biomarker and drug target [J].
Venereau, Emilie ;
De Leo, Federica ;
Mezzapelle, Rosanna ;
Careccia, Giorgia ;
Musco, Giovanna ;
Bianchi, Marco E. .
PHARMACOLOGICAL RESEARCH, 2016, 111 :534-544
[29]   DAMPs from cell death to new life [J].
Venereau, Emilie ;
Ceriotti, Chiara ;
Bianchi, Marco Emilio .
FRONTIERS IN IMMUNOLOGY, 2015, 6
[30]   HMGB1 and leukocyte migration during trauma and sterile inflammation [J].
Venereau, Emilie ;
Schiraldi, Milena ;
Uguccioni, Mariagrazia ;
Bianchi, Marco E. .
MOLECULAR IMMUNOLOGY, 2013, 55 (01) :76-82